Relay Therapeutics Hits Day High with 10.1% Surge in Strong Intraday Performance

Relay Therapeutics, Inc. has experienced a significant surge in its stock price, gaining 10.1% on June 2, 2026. The stock reached an intraday high of USD 17.46, reflecting strong market activity. This small-cap company, operating in the Pharmaceuticals & Biotechnology sector, has shown impressive performance metrics over various time frames. In the past year, Relay Therapeutics has delivered a remarkable return of 393.71%, significantly outperforming the S&P 500, which recorded a return of 28.2% during the same period. Year-to-date, the stock has risen by 85.58%, further highlighting its strong market position. The company has reported positive results for the last two consecutive quarters, with net sales for the first half of the year reaching USD 10 million. However, it is important to note that the company remains in a loss-making position, with a net profit of USD -128.18 million. Despite these challenges, Relay Therapeutics boasts high institutional holdings at 100%, indicating strong confidence from larger investors. Overall, the stock's recent performance underscores its notable activity in the market.